Pacer Advisors’s Core Laboratories CLB Stock Holding History

Pacer Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,951	Closed	-$1.76M	–	1204
2018 Q2	$1.76M	Buy	+13,951	New	+$1.7M	0.08%	331

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pacer Advisors's CLB Position: Q3 2018 in Review

Pacer Advisors sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 13,951 shares — an estimated $1.76M sold.

Pacer Advisors first reported a position in CLB in Q2 2018 and held it in 1 quarter. The position peaked at $1.76M in Q2 2018. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

Pacer Advisors reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
Pacer Advisors sold 13,951 Core Laboratories shares in Q3 2018, an estimated $1.76M.
Pacer Advisors first reported a position in Core Laboratories in Q2 2018 and held it in 1 quarter.
Pacer Advisors's Core Laboratories position peaked at $1.76M in Q2 2018.
359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Pacer Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.